What CareDx, Inc. does.

CareDx is a precision medicine company dedicated to improving outcomes for transplant patients and advancing organ health. We deliver solutions designed to empower clinicians and improve patient outcomes. The Company's integrated solutions include non-invasive molecular testing for heart, kidney, and lung transplants; laboratory products; digital health technologies; and patient solutions that support care before and after transplant. CareDx is the leading provider of genomics-based information for transplant patients. Our headquarters is located in Brisbane, California, and we have other primary operations in Omaha, Nebraska and Stockholm, Sweden.

We were originally incorporated in Delaware in December 1998 under the name Hippocratic Engineering, Inc. In April 1999, we changed our name to BioCardia, Inc., and in June 2002, we changed our name to Expression Diagnostics, Inc. In July 2007, we changed our name to XDx, Inc. and in March 2014, we changed our name to CareDx, Inc. Our principal executive offices are located at 8000 Marina Boulevard, Brisbane, California and our telephone number is (415) 287-2300. As of December 31, 2025, substantially all of our revenues came from the United States and Europe, and substantially all of our assets and operations were located in the United States and Sweden.

Revenue and profit, by fiscal year.

More on CDNA.

• CareDx, Inc. summary
• CareDx, Inc. financial statements
• CareDx, Inc. key metrics
• CareDx, Inc. health scores and style box
• CareDx, Inc. earnings
• CareDx, Inc. dividends
• CareDx, Inc. valuation
• CareDx, Inc. ownership and insiders
• CareDx, Inc. peers

Figures from CareDx, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.